Your session is about to expire
← Back to Search
Photodynamic Therapy for Brain Cancer
Study Summary
This trial is studying the side effects and best dose of a new cancer treatment called photodynamic therapy (PDT). PDT uses light and photosensitizing drugs to kill tumor cells.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- My condition cannot be treated with surgery.My condition did not improve after standard treatments, including radiation.I haven't had cancer in the last 5 years, except for skin cancer.I can receive platelet transfusions.My cancer is in one place or has only spread to one other spot.My tumor has come back or is growing and cannot be removed with surgery.My cancer is limited to one main tumor or one metastasis.I am between 3 and 70 years old.I have been diagnosed with a brain tumor.My condition did not improve after standard treatments, including radiation.My condition is getting worse or has come back.I have had a condition where my lymphocytes grow abnormally.I have a history of cancer.My liver blood tests (PT and PTT) are normal.My cancer can be reached with light treatment.You are expected to live for at least 2 more months.My condition is localized and has not spread.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age requirement for this clinical trial extend past 24 years old?
"According to the inclusion criteria, this clinical trial is open to participants between 3 and 70 years of age."
What are the potential adverse effects of this treatment?
"Due to the limited safety and efficacy data available, our team at Power rated this treatment with a score of 1 on their scale."
Could you please tell me if this clinical test is currently taking on participants?
"According to clinicaltrials.gov, this trial is presently closed; the posting was first uploaded on May 1st 1994 and last updated in September of 2013. Nonetheless, there are 657 alternative trials actively recruiting new participants at the moment."
What characteristics make certain individuals more suitable to participate in this research?
"This medical trial requires 24 participants aged between 3 and 70 who possess a CNS neoplasm. Additionally, those looking to take part must have recurrent or progressive cancer that cannot be surgically removed with negative CSF results, failed standard therapies such as radiotherapy and feature either primary tumors or solitary metastases."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger